News & Events

Latest News 

• FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID®, Targeting Mantle Cell Lymphoma
  
  
• Phase III study showed first-line maintenance use of MabThera (Rituximab) doubles likelihood of people with follicular lymphoma living without their disease worsening
   
  
• Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia
  
  
• Scientists at BC Cancer Agency unlock clues to lymphoma
   
• Researchers discover genetic clue that predicts for treatment failure in Hodgkin's Lymphoma
  

top